If your idea of fun is watching your friends and colleagues jump into icy water for a good cause on a mid-winter afternoon, you won’t want to miss Geisel’s second annual Polar Plunge, Friday, February 7, at Occom Pond.
Health apps for smartphones are nothing new. Now, health-care providers are increasingly using sophisticated technology-based medical applications to help patients manage chronic illnesses.
The Geisel School of Medicine at Dartmouth has received a $6.25 million gift from the estate of Susan Diamond, formerly of Omaha, Neb., to support research in neurology.
Lebanon, NH—Dartmouth researchers developed a new biological pathway-based computational model, called the Pathway-based Human Phenotype Network (PHPN), to identify underlying genetic connections between different diseases as reported in BioDataMining; this week. The PHPN mines the data present in large publicly available disease datasets to find shared SNPs, genes, or pathways and […]
Catherine Pipas, MD, director of the leadership component of the new curriculum at Geisel and a professor of community and family medicine, has been appointed a Faculty Member of the Association of American Medical Colleges’ Leadership Education and Development Program.
Dr. Holly Atkinson’s experiences in human rights work over the past 25 years have given her reason to be both deeply troubled and incredibly hopeful. Last week, at a symposium organized by the Geisel chapter of Physicians for Human Rights, she discussed both ends of the spectrum, from the worries that keep her up at night to the people who have inspired her.
The Choosing Wisely campaign, lists of services developed by physicians’ specialty societies, is a good start to spark discussion between physicians their patients about treatments and tests that may not be warranted.
Dartmouth engineers and radiologists are developing new approaches for an emerging technique in diagnostic imaging for breast cancer—MRI with near-infrared spectroscopy (NIRS).
Dartmouth Medicine asked geneticist Jason Moore about his thoughts on the FDA’s decision to order 23andMe, a company that provides personal genetic testing, to stop selling its genetic test for health-related purposes.
From a patient’s bedside in Mexico, Rosa Hernandez saw her future as a healer. Discover more about this first-year medical student’s journey from Los Angeles to MIT to Clínica Guadalupana in Mexico to Geisel and Dartmouth.